These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15820059)

  • 1. [Antitumor effects of interferon-gamma-inducible protein 10 combined with gemcitabine].
    Mei K; Tian L; Wei YQ; Li J; Wen YJ; Kan B; Deng HX
    Ai Zheng; 2005 Apr; 24(4):397-402. PubMed ID: 15820059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model.
    Mei K; Wang L; Tian L; Yu J; Zhang Z; Wei Y
    J Exp Clin Cancer Res; 2008 Nov; 27(1):63. PubMed ID: 18983688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model.
    Zheng SJ; Zheng SP; Huang FY; Jiao CL; Wu RL
    World J Gastroenterol; 2007 May; 13(17):2484-9. PubMed ID: 17552033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor effects of recombinant quail vascular endothelial growth factor receptor 2, as a vaccine, combined with cisplatin on LL/2 tumor model in mice].
    Hou JM; Liu JY; Yang L; Zhao X; Tian L; Lei S; Mao YQ; Wen YJ; Wei YQ
    Ai Zheng; 2005 Apr; 24(4):391-6. PubMed ID: 15820058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.
    Jia L; Zhang MH; Yuan SZ; Huang WG
    World J Gastroenterol; 2005 Jan; 11(3):447-50. PubMed ID: 15637766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
    Liu TG; Huang Y; Cui DD; Huang XB; Mao SH; Ji LL; Song HB; Yi C
    BMC Cancer; 2009 Jul; 9():250. PubMed ID: 19624862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities.
    Hou JM; Liu JY; Yang L; Zhao X; Tian L; Ding ZY; Wen YJ; Niu T; Xiao F; Lou YY; Tan GH; Deng HX; Li J; Yang JL; Mao YQ; Kan B; Wu Y; Li Q; Wei YQ
    Oncology; 2005; 69(1):81-7. PubMed ID: 16088235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors.
    Li G; Tian L; Hou JM; Ding ZY; He QM; Feng P; Wen YJ; Xiao F; Yao B; Zhang R; Peng F; Jiang Y; Luo F; Zhao X; Zhang L; Zhou Q; Wei YQ
    Clin Cancer Res; 2005 Jun; 11(11):4217-24. PubMed ID: 15930360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic treatment with three thrombospondin-1 type 1 repeats versus gemcitabine in an orthotopic human pancreatic cancer model.
    Zhang X; Galardi E; Duquette M; Lawler J; Parangi S
    Clin Cancer Res; 2005 Aug; 11(15):5622-30. PubMed ID: 16061881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma.
    Zhang R; Tian L; Chen LJ; Xiao F; Hou JM; Zhao X; Li G; Yao B; Wen YJ; Li J; Zhang L; Chen XC; Luo F; Peng F; Jiang Y; Wei YQ
    Gene Ther; 2006 Sep; 13(17):1263-71. PubMed ID: 16672984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of VEGF-trap and gemcitabine results in improved anti-tumor efficacy in a mouse lung cancer model.
    Zhou S; Yang Y; Yang Y; Tao H; Li D; Zhang J; Jiang G; Fang J
    PLoS One; 2013; 8(7):e68589. PubMed ID: 23874680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of full-length cyclin B1 antisense cDNA on chemosensitivity of lewis lung carcinoma cells to gemicitabine in vitro and in vivo].
    Zhang L; Tian L; Chen P; Zhang R; Li G; Hou JM; Yao B; Wei YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):464-7, 474. PubMed ID: 16078561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer.
    Chougule MB; Patel A; Sachdeva P; Jackson T; Singh M
    PLoS One; 2011; 6(11):e27394. PubMed ID: 22102891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine and checkpoint blockade exhibit synergistic anti-tumor effects in a model of murine lung carcinoma.
    Du B; Wen X; Wang Y; Lin M; Lai J
    Int Immunopharmacol; 2020 Sep; 86():106694. PubMed ID: 32570034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of interleukin-12 transfection on proliferation of ovarian cancer SKOV3 cells in vitro and in vivo].
    Wang J; Zhang CQ; Liu J; Sui LH
    Ai Zheng; 2007 Dec; 26(12):1292-8. PubMed ID: 18076789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis and tumor regression by vesicular stomatitis virus in the presence of gemcitabine in lung cancer.
    Li Q; Wei YQ; Wen YJ; Zhao X; Tian L; Yang L; Mao YQ; Kan B; Wu Y; Ding ZY; Deng HX; Li J; Luo Y; Li HL; He QM; Su JM; Xiao F; Zou CH; Fu CH; Xie XJ; Yi T; Tan GH; Wang L; Chen J; Liu J; Gao ZN
    Int J Cancer; 2004 Oct; 112(1):143-9. PubMed ID: 15305386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models.
    Yao B; He QM; Tian L; Xiao F; Jiang Y; Zhang R; Li G; Zhang L; Hou JM; Wang L; Cheng XC; Wen YJ; Kan B; Li J; Zhao X; Hu B; Zhou Q; Zhang L; Wei YQ
    Hum Gene Ther; 2005 Sep; 16(9):1075-86. PubMed ID: 16149906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
    Bruns CJ; Harbison MT; Davis DW; Portera CA; Tsan R; McConkey DJ; Evans DB; Abbruzzese JL; Hicklin DJ; Radinsky R
    Clin Cancer Res; 2000 May; 6(5):1936-48. PubMed ID: 10815919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine.
    Bocci G; Danesi R; Marangoni G; Fioravanti A; Boggi U; Esposito I; Fasciani A; Boschi E; Campani D; Bevilacqua G; Mosca F; Del Tacca M
    Eur J Pharmacol; 2004 Sep; 498(1-3):9-18. PubMed ID: 15363970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
    Wang ZH; Chen H; Guo HC; Tong HF; Liu JX; Wei WT; Tan W; Ni ZL; Liu HB; Lin SZ
    Int J Oncol; 2011 Nov; 39(5):1123-31. PubMed ID: 21743963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.